Tobias Klatte

16.0k total citations · 3 hit papers
277 papers, 8.9k citations indexed

About

Tobias Klatte is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Tobias Klatte has authored 277 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 188 papers in Pulmonary and Respiratory Medicine, 132 papers in Surgery and 104 papers in Molecular Biology. Recurrent topics in Tobias Klatte's work include Renal cell carcinoma treatment (150 papers), Bladder and Urothelial Cancer Treatments (114 papers) and Renal and related cancers (84 papers). Tobias Klatte is often cited by papers focused on Renal cell carcinoma treatment (150 papers), Bladder and Urothelial Cancer Treatments (114 papers) and Renal and related cancers (84 papers). Tobias Klatte collaborates with scholars based in Austria, United States and Germany. Tobias Klatte's co-authors include Allan J. Pantuck, Arie S. Belldegrun, Michela de Martino, Shahrokh F. Shariat, Fairooz F. Kabbinavar, Mesut Remzi, Matthias Waldert, Grant D. Stewart, Ilaria Lucca and Andrea Haitel and has published in prestigious journals such as Nature, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Tobias Klatte

273 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update

2022 810 citations Milan Hora, Tobias Klatte et al. profile →
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy

2015 429 citations Tobias Klatte et al. profile →
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update

2025 18 citations Riccardo Campi, Milan Hora et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tobias Klatte Austria	48	5.8k	3.9k	2.6k	2.1k	2.0k	277	8.9k
A. Ari Hakimi United States	45	4.9k 0.8×	4.4k 1.1×	1.3k 0.5×	2.1k 1.0×	2.9k 1.4×	229	8.3k
Jens Bedke Germany	36	3.9k 0.7×	2.7k 0.7×	2.8k 1.1×	3.0k 1.4×	1.4k 0.7×	313	7.6k
David G. McLeod United States	61	9.7k 1.7×	3.0k 0.8×	1.9k 0.7×	2.5k 1.2×	2.4k 1.2×	271	13.3k
Arnaud Méjean France	43	3.9k 0.7×	2.6k 0.7×	2.0k 0.8×	1.4k 0.7×	1.2k 0.6×	226	7.1k
Pierre I. Karakiewicz Canada	53	8.8k 1.5×	3.7k 0.9×	2.8k 1.0×	1.9k 0.9×	1.7k 0.8×	405	10.3k
R. Jeffrey Karnes United States	59	8.5k 1.5×	2.3k 0.6×	2.8k 1.1×	2.0k 0.9×	2.4k 1.2×	428	12.4k
Peter Venner Canada	40	4.8k 0.8×	1.9k 0.5×	1.8k 0.7×	3.3k 1.6×	1.5k 0.8×	116	8.4k
Ken Nakagawa Japan	44	5.5k 1.0×	2.7k 0.7×	1.9k 0.7×	4.0k 1.9×	1.8k 0.9×	319	9.6k
Joseph C. Presti United States	58	7.8k 1.4×	1.7k 0.4×	2.5k 0.9×	2.0k 0.9×	1.5k 0.8×	239	10.5k
Jae‐Lyun Lee South Korea	47	5.2k 0.9×	2.7k 0.7×	4.7k 1.8×	6.2k 2.9×	1.7k 0.8×	394	11.4k

Countries citing papers authored by Tobias Klatte

Since Specialization

Citations

This map shows the geographic impact of Tobias Klatte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Klatte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Klatte more than expected).

Fields of papers citing papers by Tobias Klatte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Klatte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Klatte. The network helps show where Tobias Klatte may publish in the future.

Co-authorship network of co-authors of Tobias Klatte

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Klatte. A scholar is included among the top collaborators of Tobias Klatte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Klatte. Tobias Klatte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pyrgidis, Nikolaos, Gerald Bastian Schulz, Francesco Pellegrino, et al.. (2025). The role of salvage cystectomy after prior trimodality therapy.. Journal of Clinical Oncology. 43(5_suppl). 781–781.

Krause, Hans, et al.. (2024). Retrospective analysis of partial cystectomy in patients with muscle-invasive urothelial carcinoma: A German single-center experience. Urologic Oncology Seminars and Original Investigations. 43(3). 188.e1–188.e8. 1 indexed citations

Klatte, Tobias, Sefer Elezkurtaj, Maria De Santis, et al.. (2023). Presence of CD8⁺ cytotoxic T-cells in proximity to tumor cells, TIM3, CTLA-4 and prognostic implications for muscle-invasive urothelial cancer.. Journal of Clinical Oncology. 41(16_suppl). 4582–4582. 1 indexed citations

Kluth, Martina, Maximilian Lennartz, Niclas C. Blessin, et al.. (2023). MYC amplifications are a common event in urothelial bladder carcinomas associated with an aggressive tumor phenotype. American Journal of Clinical Pathology. 160(Supplement_1). S91–S92. 1 indexed citations

Klatte, Tobias, et al.. (2023). Renal functional and cardiovascular outcomes of partial nephrectomy versus radical nephrectomy for renal tumors: a systematic review and meta-analysis. Urologic Oncology Seminars and Original Investigations. 41(3). 113–124. 7 indexed citations

Byrne, Matthew H V, Fanourios Georgiades, Alexander Light, et al.. (2022). Impact of COVID ‐19 on the management and outcomes of ureteric stones in the UK : a multicentre retrospective study. British Journal of Urology. 131(1). 82–89. 7 indexed citations

Diana, Pietro, Tobias Klatte, Daniele Amparore, et al.. (2022). Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group. World Journal of Urology. 41(4). 929–940. 18 indexed citations

Usher‐Smith, Juliet A., Hannah Harrison, Sabrina H. Rossi, et al.. (2021). Risk models for recurrence and survival after kidney cancer: a systematic review. British Journal of Urology. 130(5). 562–579. 21 indexed citations

Pivovarčíková, Kristýna, Reza Alaghehbandan, Tobias Klatte, et al.. (2018). Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF–III renal cysts: a multicenter study. World Journal of Urology. 36(6). 905–911. 14 indexed citations

10.

Hennig, Martin, Julian P. Struck, A. Cebulla, et al.. (2018). Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current Practice. Urologia Internationalis. 101(1). 25–30. 4 indexed citations

11.

Mari, Andrea, David D‘Andrea, Shoji Kimura, et al.. (2018). Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer. Urologia Internationalis. 101(2). 197–200. 12 indexed citations

12.

Soria, Francesco, Ilaria Lucca, Marco Moschini, et al.. (2017). Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer. Urologic Oncology Seminars and Original Investigations. 35(6). 356–362. 4 indexed citations

13.

Soria, Francesco, Marco Moschini, Andrea Haitel, et al.. (2016). The effect of HER2 status on oncological outcomes of patients with invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 34(12). 533.e1–533.e10. 18 indexed citations

14.

Klatte, Tobias, et al.. (2015). Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1,391 prospective documented patients. Surgery. 159(2). 503–511. 24 indexed citations

15.

Martino, Michela de, Dazhong Zhuang, Tobias Klatte, et al.. (2014). Impact ofERBB2mutations on in vitro sensitivity of bladder cancer to lapatinib. Cancer Biology & Therapy. 15(9). 1239–1247. 29 indexed citations

16.

Klatte, Tobias, Évanguelos Xylinas, Malte Rieken, et al.. (2014). Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Urologic Oncology Seminars and Original Investigations. 32(5). 625–630. 20 indexed citations

17.

Klatte, Tobias, Priya Rao, Michela de Martino, et al.. (2009). Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma. Journal of Clinical Oncology. 27(5). 746–753. 151 indexed citations

18.

Klatte, Tobias & Allan J. Pantuck. (2008). Molecular Biology of Renal Cortical Tumors. Urologic Clinics of North America. 35(4). 573–580. 25 indexed citations

19.

Shuch, Brian, Tobias Klatte, Stephen B. Riggs, et al.. (2008). Performance status and cytoreductive nephrectomy. Cancer. 113(6). 1324–1331. 45 indexed citations

20.

Klatte, Tobias, Arie S. Belldegrun, & Allan J. Pantuck. (2008). The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder. British Journal of Urology. 101(s4). 45–48. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact